| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Fusidic acid poisoning (disorder) |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental fusidic acid poisoning (disorder) |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional fusidic acid poisoning |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par l'acide fusidique d'intention indéterminée |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid adverse reaction |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to fusidic acid (finding) |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fusidic acid overdose |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental fusidic acid overdose |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional fusidic acid overdose (disorder) |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose de acide fusidique d'intention indéterminée |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fusidic acid [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fusidic acid 1% m/r eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fusidic acid 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing fusidic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical fusidic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium fusidate (substance) |
Is a |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing betamethasone and fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Accidental fusidic acid poisoning (disorder) |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional fusidic acid poisoning |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fusidic acid- and hydrocortisone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing fusidic acid in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing fusidic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to fusidic acid (finding) |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Sodium fusidate (substance) |
Is modification of (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fusidic acid 50 mg/mL oral suspension |
Has precise active ingredient |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid 50 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely fusidic acid 10 milligram/1 gram prolonged-release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely fusidic acid 10 milligram/1 gram prolonged-release eye drops (clinical drug) |
Has precise active ingredient |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid 20 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid 20 mg/g cutaneous cream |
Has precise active ingredient |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
Has precise active ingredient |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing betamethasone and fusidic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Fusidic acid- and hydrocortisone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only betamethasone and fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid and hydrocortisone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only fusidic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Betamethasone and fusidic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely fusidic acid 10 milligram/1 gram conventional release suspension for eye drops (clinical drug) |
Has precise active ingredient |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely fusidic acid 10 milligram/1 gram conventional release suspension for eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fusidic acid anhydrous (substance) |
Is modification of (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]